Evolent program achieves 20% reduction in use of low-value oncology regimens

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. WYFI
6. STUB
7. EAT
8. ARX
9. BTGO
10. NVDA

Go back to Evolent program achieves 20% reduction in use of low-value oncology regimens
(NYSE: EVH) Delayed: 4.66 +0.49 (11.75%)
Previous Close $4.17    52 Week High $26.84 
Open $4.22    52 Week Low $8.14 
Day High $4.67    P/E N/A 
Day Low $4.20    EPS $0.00 
Volume 3,722,743